Computational platform Way2Drug: from the prediction of biological activity to drug repurposing


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The Way2Drug informational-computational platform (www.way2drug.com/dr) provides access to the data on drugs approved for medicinal use in the USA and Russian Federation, as well as computational possibilities for the prediction of biological activity of drug-like organic compounds. Currently realized computational tools of the platform, which allow one to predict several thousands of biological activity types, including the interaction with molecular targets, pharmacotherapeutic and side effects, metabolism, acute toxicity for rats, cytotoxicity, influence on gene expression, and other properties characterizing the evaluation how promising are particular drug-like compounds as potential pharmaceuticals, are reviewed. Using the Way2Drug platform, one can not only select the most promising "hits" for the synthesis and testing of biological activity but also reveal new indications for the launched drugs.

Авторлар туралы

D. Druzhilovskiy

Institute of Biomedical Chemistry

Хат алмасуға жауапты Автор.
Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

A. Rudik

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

D. Filimonov

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

T. Gloriozova

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

A. Lagunin

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

A. Dmitriev

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

P. Pogodin

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

V. Dubovskaya

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

S. Ivanov

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

O. Tarasova

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

V. Bezhentsev

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

K. Murtazalieva

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

M. Semin

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

I. Maiorov

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

A. Gaur

CSIR-Indian Institute of Chemical Technology

Email: dmitry.druzhilovsky@ibmc.msk.ru
Үндістан, Hyderabad, 500 007

G. Sastry

CSIR-Indian Institute of Chemical Technology

Email: dmitry.druzhilovsky@ibmc.msk.ru
Үндістан, Hyderabad, 500 007

V. Poroikov

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Ресей, 10/8 Pogodinskaya ul., Moscow, 119121

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2017